FDA Adverse Event
Injury
Summary report: N
ENDOTAK RELIANCE
MDR report key: 1875084
·
Received October 19, 2010
Report
- Report Number
- 2124215-2010-18739
- Event Type
- Injury
- Date Received
- October 19, 2010
- Date of Event
- September 9, 2010
- Report Date
- September 9, 2010
- Manufacturer
- CPI - DEL CARIBE
- Product Code
- NVY
- Adverse Event
- Yes
- Product Problem
- Yes
- Report Source
- Manufacturer report
- Reporter Occupation
- MEDICAL EQUIPMENT COMPANY TECHNICIAN/REPRESENTATIVE
Narratives
Additional Manufacturer Narrative · 1
THE RATE/SENSE PORTION OF THE LEAD WAS CAPPED AND A NEW RATE/SENSE LEAD WAS IMPLANTED. THE SHOCK PORTION OF THE LEAD REMAINS IN SERVICE. SHOULD ADDITIONAL INFORMATION BECOME AVAILABLE, THIS EVENT WILL BE UPDATED.
Description of Event or Problem · 1
BOSTON SCIENTIFIC CRM RECEIVED INFORMATION THAT THIS IMPLANTABLE DEFIBRILLATION LEAD EXHIBITED AN INCREASE IN PACING THRESHOLD MEASUREMENTS. LOSS OF CAPTURE WAS ALSO NOTED. NO ADVERSE PATIENT EFFECTS WERE REPORTED.
Devices
| Seq | Brand | Generic | Product Code | Manufacturer | Model | Lot | UDI-DI |
|---|---|---|---|---|---|---|---|
| 1 | ENDOTAK RELIANCE | IMPLANTABLE LEAD | NVY | CPI - DEL CARIBE | 0175 |
Patients
| Seq | Age | Sex | Outcome | Treatment |
|---|---|---|---|---|
| 1 | 71 YR | Required Intervention | 0175| 5076| 4194| N119 |